MedTrace Logo

A Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitivity

NCT03965039 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-10-30

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the efficacy (changes in dentinal hypersensitivity) and safety (oral soft tissue evaluation) after use of one of four dentifrices in subjects with pre-existing hypersensitivity over an 11-week period.

Conditions

  • Dentin Hypersensitivity

Interventions

DEVICE

Dipotassium oxalate toothpaste

Experimental dipotassium oxalate (3%) toothpaste

DRUG

Stannous fluoride toothpaste

Marketed stannous fluoride (0.454%) toothpaste

DRUG

Potassium nitrate toothpaste

Marketed potassium nitrate (5%) toothpaste

DRUG

Sodium monofluorophosphate toothpaste

Marketed sodium monofluorophosphate (0.76%) toothpaste

Sponsors & Collaborators

  • Procter and Gamble

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-08
Primary Completion
2019-10-03
Completion
2019-10-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03965039 on ClinicalTrials.gov